Mostrar el registro sencillo del ítem

dc.contributor.authorGarcía Camacho, Carlos
dc.contributor.authorMarín Paz, Antonio Jesús 
dc.contributor.authorLagares Franco, Carolina María 
dc.contributor.authorAbellán Hervás, Josefa 
dc.contributor.authorSainz Otero, Ana María 
dc.contributor.otherEnfermería y Fisioterapiaes_ES
dc.contributor.otherEstadística e Investigación Operativaes_ES
dc.date.accessioned2020-11-24T12:02:24Z
dc.date.available2020-11-24T12:02:24Z
dc.date.issued2020-11-23
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10498/23979
dc.description.abstractIntroduction. Hyperlactatemia occurs during or after extracorporeal circulation in the form of lactic acidosis, increasing the risk of postoperative complications and the mortality rate. The aim of this study was to evaluate whether continuous high-volume hemofiltration with volume replacement through a polyethersulfone filter during the extracorporeal circulation procedure decreases postoperative lactatemia and its consequences. ||Materials and methods. This was a randomized controlled trial. Patients were randomly divided into two groups of 32: with or without continuous high-volume hemofiltration through a polyethersulfone membrane. Five patients were excluded from each group during the study period. The sociodemographic characteristics, filter effects, and blood lactate levels at different times during the procedure were evaluated. Secondary endpoints were studied, such as the reduction in the intubation time and time spent in ICU. ||Results. Lactatemia measurements performed during the preoperative and intraoperative phases were not significantly different between the two groups. However, the blood lactate levels in the postoperative period and at 24 hours in the intensive care unit showed a significant reduction and a possible clinical benefit in the hemofiltered group. Following extracorporeal circulation, the mean lactate level was higher (difference: 0.77 mmol/L; CI 0.95: 0.01–1.53) in the nonhemofiltered group than in the hemofiltered group (p<0.05). This effect was greater at 24 hours (p = 0.019) in the nonhemofiltered group (difference: 1.06 mmol/L; CI 0.95: 0.18–1.93) than in the hemofiltered group. The reduction of lactatemia is associated with a reduction of inflammatory mediators and intubation time, with an improvement in liver function. || Conclusions. The use and control of continuous high-volume hemofiltration through a polyethersulfone membrane during heart-lung surgery could potencially prevent postoperative complications. The reduction of lactatemia implied a reduction in intubation time, a decrease in morbidity and mortality in the intensive care unit and a shorter hospital stay.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePLOS ONE 15(11): e0242411.es_ES
dc.subjectHemofiltrationes_ES
dc.subjectCardiac surgeryes_ES
dc.subjectIntensive Care Unites_ES
dc.subjectIntubationes_ES
dc.subjectNursinges_ES
dc.subjectPerfusionistes_ES
dc.subjectLactatees_ES
dc.subjectUltrafiltrationes_ES
dc.subjectExtracorporeal circulationes_ES
dc.titleContinuous ultrafiltration during extracorporeal circulation and its effect on lactatemia: A randomized controlled triales_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.description.physDesc14 páginas.es_ES
dc.identifier.doi10.1371/journal.pone.0242411


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Internacional